UK Clinical Pharmacy Association

Magnesium aspartate

Issues for surgery

Risk of hypomagnesaemia if omitted.

Risk of hypermagnesemia if continued, particularly if renal impairment present.

Advice in the perioperative period

Elective and emergency surgery


Consider checking serum magnesium, potassium, and calcium levels pre-operatively.

Post-operative advice

Restart post-operatively as soon as the next dose is due, if still required. If the patient is unable to resume their usual oral medication post-operatively, supplementation with intravenous (IV) magnesium can be considered.

If continued, consider monitoring serum magnesium.

Monitor renal function – consult product literature if renal impairment occurs post-operatively.

Patients undergoing gastrointestinal surgery

Some patients who have bowel resection surgery will have reduced magnesium absorption and will be at risk of hypomagnesaemia. The extent of magnesium malabsorption will be dependent upon the degree of resection and the remaining length of bowel following surgery.

Interactions with common anaesthetic agents


Interactions with other common medicines used in the perioperative period

Magnesium is likely to affect the absorption of other oral medicines, hence manufacturers generally advise a time interval of 2 – 3 hours, if possible, between administration. See also Antimicrobials and Oral iron below.


Effects on absorption

Magnesium may affect the absorption of oral quinolones, tetracyclines and nitrofurantoin if given at the same time. Tetracycline administration should be separated from magnesium administration by 2 to 3 hours. Administration of quinolones or nitrofurantoin should be separated from magnesium administration by 3 to 4 hours.


Aminoglycosides (e.g., gentamicin) may increase magnesium losses via the kidneys therefore an increase in magnesium dose may be necessary. Whilst single surgical prophylactic doses should not pose a problem, bear the interaction in mind if a course of antimicrobial treatment is required.

Oral iron

Magnesium may affect the absorption of oral iron if given at the same time. Administration should be separated by 3 to 4 hours.

Proton pump inhibitors

Long-term use of proton pump inhibitors has been associated with hypomagnesaemia, possibly due to disturbances in absorption. Consider switching to a histamine H2-receptor antagonist if hypomagnesaemia is refractory to treatment and it is appropriate to switch.

Further information

None relevant.


Summary of Product Characteristics – Magnaspartate® [magnesium aspartate dihydrate] 243mg Powder for Oral Solution. Kora Healthcare. Accessed via 10th April 2023 [date of revision of the text March 2022]

Joint Formulary Committee. British National Formulary (online) London: BMJ Group and Pharmaceutical Press. [Accessed on 10th April 2023]

Baxter K, Preston CL (eds), Stockley’s Drug Interactions (online) London: Pharmaceutical Press. [Accessed on 10th April 2023]

Magnesium. In: Brayfield A (Ed), Martindale: The complete Drug Reference. London: Pharmaceutical Press. [Accessed on 14th July 2023]